I Use Ketamine for Depression – Here’s How It Works.
FREETHINK: When first manufactured as an anesthetic for humans and animals in 1962, doctors had no intention of prescribing ketamine for depression. And after...
Ehave (EHVVF) Looks to Power the Psychedelics Revolution
Mental illness will cost the global economy $16 trillion by 2030 due to early-onset and lost productivity, with an estimated 12 billion working days lost due...
Ehave (EVVHF) Hires Institutional Review Board (IRB) As It Solidifies Partnership With Tristar Wellness...
Institutional Review Board (IRB) reviews proposed research protocols to protect human subjects involved in research.
MIAMI, July 09, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC...
Psychedelic Investor Conferences.
Not Quite as Popular as the Bitcoin 2021 Conference Attended by 12,000 - But Worth Considering!
Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit (July...
Psychedelic Primer Guide. (Psychedelic Medicine Association)
The Psychedelic Medicine Association (PMA) is a society of physicians, therapists, and health care professionals looking to advance their education on the therapeutic uses...
Greenbrook Health Centers (GBNH) Changing the Way Depression is Treated.
Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence
https://youtu.be/yrr-wlFftT0
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology...
Adding Ehave (EHVFF) $0.04 to Psychedelic Watch List.
Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low. Launching Clinical Trial With Brain Scientific to Monitor Ketamine Efficacy.Launching Clinical...
The FDA Cracks Down On Stem Cell Therapy.
Due to a somewhat unexpected crackdown on stem cell treatment centers a couple of weeks ago - we have decided to hold off launching...
The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same (New York Times).
Summary: MAPS is featured in an article on the front page of today's edition of The New York Times!
Reporter Andrew Jacobs profiles MAPS Founder and...
Advances in Psychedelics can Change Investors’ Minds
Original article(s) on EXBulletin and Financial Times
The science behind this subject has become mainstream in recent years. Excellent BBC documentary Psychedelic trial We explored the implications...
Latest article
Jeffrey Gundlach: Reckoning is Coming.
Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm.
On 11 November 2020, Gundlach remarked in an interview with...
Who’s the Next Eric Sprott?
To say Eric Sprott has left a legendary mark on the world of mining investment would be an understatement. With a career spanning five...
Perpetua (PPTA) Raises $300 Million.
Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...
